BD MAX™ Resources

Our resource database provides you with everything you need to take your BD MAX™ to the next level

Solutions portfolio on BD MAX™ System to meet your diverse molecular testing needs

BD MAX™ System


BD MAX™ System

How can you achieve MAX efficiency? Optimize patient care with speed and accuracy

How can you achieve MAX performance? Diagnostics that help improve testing accuracy and patient management

How can you achieve MAX versatility? With clinically relevant and differentiated menu offerings

Request info

Healthcare-associated infection (HAI)

General Cdiff MRSA / StaphSR

Greater sensitivity with simplified workflow

Request info

Simplify the standard of care for your presurgical screening

Request info

Gastrointestinal infection (GI)

General Bacterial Panel Parasite Panel Viral Panel

Simplify gastroenteritis testing with enhanced accuracy and sensitivity

Request info

Sexually-transmitted infection (STI)

General CT/GC/TV Vaginal Panel GBS

Get her vaginitis diagnosis right the first time with the BD MAX™ Vaginal Panel

Request info

Respiratory tract infection (RTI)

General SARS-CoV-2 / Flu / RSV MDR-TB Others

Innovation that simplifies. Clinical differentiation that counts

Innovation that simplifies. Clinical differentiation that counts.

Request info

Advance the standard of testing for multidrugresistant tuberculosis (MDR-TB)

Request info

Ready to take your diagnostic potential to new heights?

Contact us

Access all BD MAX™ IFUs

Secure the most up-to-date BD MAX™ user’s manuals.


Decontamination guide

for BD MAX™ System


Technical service email

Technical service number

+34 918488173 


Technical service email

Technical service number

+39 02 4824 0600


United Kingdom

Technical service email

Technical service number

+44 (0) 800 917 8776

Deep dive into the BD MAX™ System

Get the most out of your BD MAX™ with our learning centre and webinars

How do other BD MAX™ users engage their platform?

How has NHS Chesterfield Royal Hospital optimized bed management?
April, 2019

“The major advantage of using the BD MAX in the laboratory, it’s a very easy system to use. It’s actually support staff driven, which means it takes away a lot of the specialist biomedical scientists”

Watch now

How did the BD MAX™ System help Bio 67 lab improve patient management?
April, 2019

“We found twice as many positive results as before that’s what makes the BD MAX™ solution unique: it’s incredibly sensitive as the results were confirmed in culture retrospectively so the screening was accurate and enabled us to deliver quick, relevant and trustworthy results.”

Watch now

Why join BD MAX™ Club?

Connect with professionals from around the world BD MAX™ Club members represent a community of professionals in infectious diseases and molecular diagnostics. With regional meet-ups and live webinars from global experts, expand your laboratory’s network and collaborate with worldwide colleagues.

Tailored medical and technical expertise Whether you need compelling scientific research or tutorials for troubleshooting on the BD MAX™ System, BD MAX™ Club is here to accompany your molecular diagnostics journey. Log in to your BD MAX™ Club account anywhere, anytime to access our information database.

Exclusive members’ perks BD MAX™ Club membership unlocks doors to exclusive webinars and collaboration with industry leading experts. Engage with your colleagues in the molecular community and exchange with the BD research and development team.

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company’s control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.